In 2016, the transaction volumes of private biopharma companies that do not product orphan products reached 19.6 billion U.S. dollars, whereas the values for companies that produce orphan products was 1.3 billion U.S. dollars. This statistic shows the M&A transaction volumes of private venture capital-backed orphan biopharma companies in U.S. and Europe from 2014 to 2019.
M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019
(in billion U.S. dollars)
Characteristic
Orphan-product companies
Other companies
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Total transaction values (including contingent payments) of completed trade sales of private VC-backed U.S. and European biopharma
companies (all transaction sizes).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
HBM Partners. (February 1, 2020). M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019 (in billion U.S. dollars) [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/1093712/vc-orphan-biopharma-company-trade-sales-transaction-volumes-us-europe/
HBM Partners. "M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019 (in billion U.S. dollars)." Chart. February 1, 2020. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/1093712/vc-orphan-biopharma-company-trade-sales-transaction-volumes-us-europe/
HBM Partners. (2020). M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/1093712/vc-orphan-biopharma-company-trade-sales-transaction-volumes-us-europe/
HBM Partners. "M&a Transaction Volumes of Private U.S. and European Vc-backed Orphan Biopharma Companies from 2014 to 2019 (in Billion U.S. Dollars)." Statista, Statista Inc., 1 Feb 2020, https://www.statista.com/statistics/1093712/vc-orphan-biopharma-company-trade-sales-transaction-volumes-us-europe/
HBM Partners, M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1093712/vc-orphan-biopharma-company-trade-sales-transaction-volumes-us-europe/ (last visited September 01, 2024)
M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019 (in billion U.S. dollars) [Graph], HBM Partners, February 1, 2020. [Online]. Available: https://www.statista.com/statistics/1093712/vc-orphan-biopharma-company-trade-sales-transaction-volumes-us-europe/